- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BIBW 2992 MA2 20mg/day
Total 543 results
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
New Cancer Cure-Bio Co.,Ltd.RecruitingAdvanced Solid TumorsKorea, Republic of
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University of GuadalajaraCompletedMetabolic Syndrome
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedGliomaUnited States, Canada
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Maxinovel Pty., Ltd.Not yet recruitingAdvanced / Metastatic Solid Tumors
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, United Kingdom
-
Boehringer IngelheimCompleted
-
EnnovaBio Australia Pharmaceuticals Pty LtdCompleted
-
Boehringer IngelheimCompleted
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRecurrent Bladder Cancer | Stage III Bladder Cancer | Stage IV Bladder Cancer | Ureter Cancer | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Stage III Urethral Cancer | Stage IV Urethral CancerUnited States
-
Centre Leon BerardBoehringer IngelheimCompletedHead and Neck Squamous Cell CarcinomaFrance
-
Inmagene LLCRecruiting
-
Shanghai Jiatan Pharmatech Co., LtdCompleted
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
-
Victoria Arija ValCarlos III Health Institute; Catalan Institute of Health; University Rovira i... and other collaboratorsCompletedAnemia Ferropenic | Risk of Hemoconcentration (Iron Levels >130g/L)Spain
-
Dong-A ST Co., Ltd.CompletedOsteoarthritis, KneeKorea, Republic of
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungAustralia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBreast NeoplasmsBelgium, Germany
-
Boehringer IngelheimCompletedNeoplasmsUnited Kingdom
-
BioMarin PharmaceuticalCompletedPhenylketonuria (PKU)United States
-
M.D. Anderson Cancer CenterBoehringer IngelheimTerminatedLung CancerUnited States
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungItaly
-
Medical University of South CarolinaBoehringer IngelheimWithdrawnLung CancerUnited States
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Taiwan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
University College, LondonBoehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Belgium, Canada, China, France, Germany, Hong Kong, Italy, Korea, Republic of, Netherlands, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Boehringer IngelheimTerminatedNeoplasmsUnited States, Taiwan
-
ETOP IBCSG Partners FoundationCompleted
-
Universitätsklinikum Hamburg-EppendorfBoehringer IngelheimTerminated
-
University of ReadingUnknown
-
Krzysztof MisiukiewiczSanofi; Icahn School of Medicine at Mount SinaiCompleted
-
Instituto Nacional de Cancerologia de MexicoCompletedNon-Small Cell Lung Cancer | EGFR | HER-2Mexico
-
University of ReadingCompletedVasodilationUnited Kingdom
-
Boehringer IngelheimCompleted